| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |